4.20
-4.55%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Adicon Holdings
Its shares trade on HKEX under the ticker 9860.HK. It has been listed since 30 June 2023. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.64bn and net income of CN¥18.4m. At that date it held total assets of CN¥4.80bn and shareholders' equity of CN¥1.72bn.
ADICON Holdings Ltd. engages in the provision of independent clinical laboratory services. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2023-06-30. The firm primarily provides testing services to hospitals, medical institutions, medical examination centers, consumers, pharmaceutical companies and contract research organizations (CROs). The firm's inspection services mainly include routine tests, esoteric tests, clinical immunologic testing, clinical chemistry testing, clinical molecular biology testing, pathology testing and others testing. The firm is also engaged in the sales of medical testing equipment. The firm principally conducts its businesses in the domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 30 Jun 2023
- Employees
- 5,917
- Website
- adicon.com.cn ↗
Leadership
Pay as last reported
- Ms. Ling YangNon-Executive Chairman of the Board
- Mr. Song GaoChief Executive Officer, Executive Director, since 2019CN¥6.1m
- Mr. Lawrence WangChief Financial Officer, Senior Vice President, Joint Company Secretary
- Mr. Chao PanSenior Vice President, Head - Laboratory
- Ms. Yuanyuan HuVice President
- Mr. Jianing ChuInternal Audit Director, Strategic Intelligence Officer
- Ms. Dan LiNational Quality Director
- Mr. Chengdong WangNational Purchasing Director, National Project Management Director
- Ms. Ka Man SoJoint Company Secretary
- Ms. Junyuan FengNon-Executive Director
- Dr. Jixun LinNon-Executive Director, since 2008
- Mr. Mintao ZhouNon-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Adicon Holdings Ltd employs 5917 full-time employees in Hangzhou, China.
- The company provides comprehensive clinical laboratory services to hospitals and pharmaceutical companies.
- Adicon offers a wide range of testing services including molecular biology and pathology testing.
Weaknesses
- Adicon's business is primarily focused on the domestic Chinese market.
- The company has only one headquarters city, Hangzhou, for its operations.
- Adicon's IPO was recently on 30 June 2023, limiting its market experience.
Opportunities
- Adicon can expand its services to international markets beyond China.
- The growing demand for clinical laboratory services in China presents opportunities.
- Adicon's sales of medical testing equipment can increase with market growth.
Threats
- Adicon faces competition from other domestic clinical laboratory providers in China.
- Regulatory changes in China's healthcare sector could impact operations.
- Economic downturns in China may reduce demand for medical testing services.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.